Details for New Drug Application (NDA): 050627
✉ Email this page to a colleague
The generic ingredient in RIFADIN is rifampin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Summary for 050627
Tradename: | RIFADIN |
Applicant: | Sanofi Aventis Us |
Ingredient: | rifampin |
Patents: | 0 |
Suppliers and Packaging for NDA: 050627
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIFADIN | rifampin | INJECTABLE;INJECTION | 050627 | NDA | Sanofi-Aventis U.S. LLC | 0068-0597 | 0068-0597-01 | 1 VIAL, GLASS in 1 CARTON (0068-0597-01) / 10 mL in 1 VIAL, GLASS |
RIFADIN | rifampin | INJECTABLE;INJECTION | 050627 | NDA | Sanofi-Aventis U.S. LLC | 0068-0599 | 0068-0599-01 | 1 VIAL, GLASS in 1 CARTON (0068-0599-01) / 10 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 600MG/VIAL | ||||
Approval Date: | May 25, 1989 | TE: | AP | RLD: | Yes |
Complete Access Available with Subscription